Cipla Overview

  • Founded
  • 1935
Founded
  • Status
  • Public
  • Employees
  • 21,565
Employees
  • Stock Symbol
  • 500087
Stock Symbol
  • Investments
  • 27
  • Share Price
  • $13.79
  • (As of Thursday Closing)

Cipla General Information

Description

Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large global presence. Cipla's growth strategy focuses on new product launches.

Contact Information

Website
www.cipla.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
BOM
Primary Office
  • Cipla House, Peninsula Business Park
  • Ganpatrao Kadam Marg, Lower Parel
  • Mumbai, Maharashtra 400013
  • India
+91 022 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cipla Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.79 $13.84 $10.16 - $14.16 $11.2B 807M 453K $0.43

Cipla Financials Summary

In Thousands,
USD 		TTM 31-Dec-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 9,874,997 8,859,213 4,678,419 6,421,835
Revenue 2,842,751 2,556,883 2,368,195 2,308,184
EBITDA 629,305 591,251 478,489 468,650
Net Income 347,322 323,236 217,665 218,266
Total Assets 3,424,551 3,137,438 3,450,478
Total Debt 0 274,272 409,600 621,494
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cipla Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cipla‘s full profile, request access.

Request a free trial

Cipla Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product po
Drug Discovery
Mumbai, India
21,565 As of 2021
00000000

00000 00

llamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vo
0000 000000000
Mumbai, India
00000 As of 0000
00000
0.000 0000-00-00
00000000 00000

00000 00

ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
000000000000000
Ahmedabad, India
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cipla Competitors (35)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alkem Laboratories Formerly PE-Backed Mumbai, India 00000 00000 00000000 00000
00000 000000 Corporation Ahmedabad, India 00000 00000000
00000000 00000 Corporation Hyderabad, India 0000 000.00 000000000000
0000000 0000000000 Corporation Ahmedabad, India 00000 0000 00000000000 0000
00000000 000000000 Corporation Mumbai, India 00000 00000 000000000 00000
You’re viewing 5 of 35 competitors. Get the full list »

Cipla Patents

  • 1,371

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 53

    Granted

  • 20

    Pending

  • 000

    Expiring in next 12 mo

Cipla Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210299098-A1 Selective estrogen receptor modulator for treatment of pancreatic cancer Pending 31-Mar-2020 000000000
AU-2020260764-A1 Methods and systems for simulating deposition of inhaled drug on lungs Pending 24-Apr-2019 000000000
US-20210379080-A1 Intranasal formulation Pending 18-Dec-2018 00000000000
EP-3897577-A1 Intranasal formulation Pending 18-Dec-2018 0000000000
US-20210196721-A1 Stable pharmaceutical formulations of pemetrexed Pending 20-Nov-2018 A61K31/519
To view Cipla’s complete patent history, request access »

Cipla Executive Team (51)

Name Title Board Seat Contact Info
Umang Vohra Chief Executive Officer & Board Member
Arunesh Verma Chief Executive Officer, North America
Kedar Upadhye Global Chief Financial Officer & President
Raju Mistry Global Chief People Officer & President
Ajay Luharuka Chief Financial Officer - North America, IPD & Global API
You’re viewing 5 of 51 executive team members. Get the full list »

Cipla Board Members (15)

Name Representing Role Since
0000 0000000000 Self Board Member 000 0000
00000 00000 Self Board Member 000 0000
0.0. 000000000 Self Board Member 000 0000
0.0. 000000 Self Non Executive Vice Chairman 000 0000
00000 000000 Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Cipla Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cipla Investments & Acquisitions (27)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 25-Aug-2021 00000 0000 Biotechnology 00000 000
00000000 31-Oct-2020 000000000 00.000 Other Healthcare Technology Systems
00000 0000000 01-Jul-2020 0000000000 00.000 Buildings and Property 00000 000
0000000 (0000 08-Feb-2020 000000000 000.00 Buildings and Property 000000 00
Novartis (brand name and trademark rights for Vysov and Vysov M (Vildagliptin and Metformin) 10-Dec-2019 Corporate Asset Purchase 00.000 Buildings and Property 00000 000
You’re viewing 5 of 27 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Cipla Subsidiaries (3)

Company Name Industry Location Founded
Cipla New Ventures Impact Investing Mumbai, India 2013
00000000 Pharmaceuticals George, South Africa 0000
00000 000000 00000 Pharmaceuticals Bellville, South Africa 0000
To view Cipla’s complete subsidiaries history, request access »

Cipla Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 000000000 22-May-2015 000000000000000000 0000 Completed
  • 00000
00000 0000000 04-Dec-2013 000000000000000000 Completed
  • 00000
0000000 000000 000 13-Aug-2012 000000000 00000 Completed
  • 00000
Desano Holdings 31-Mar-2011 Corporate Completed
To view Cipla’s complete exits history, request access »